Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis ; volume:35 ; number:9 ; day:9 ; month:8 ; year:2021 ; pages:985-997 ; date:9.2021
CNS drugs ; 35, Heft 9 (9.8.2021), 985-997, 9.2021
- Creator
-
Bar-Or, Amit
O’Brien, Susan M.
Sweeney, Michael L.
Fox, Edward J.
Cohen, Jeffrey A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s40263-021-00843-8
- URN
-
urn:nbn:de:101:1-2021111407061624750546
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Bar-Or, Amit
- O’Brien, Susan M.
- Sweeney, Michael L.
- Fox, Edward J.
- Cohen, Jeffrey A.
- SpringerLink (Online service)
Other Objects (12)
Dental Adverse Effects of Anti-CD20 Therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Nutritional and pharmacological attributes of baobab fruit pulp
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany
Current and future pharmacological therapies for NAFLD/NASH
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Dental Adverse Effects of Anti-CD20 Therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Nutritional and pharmacological attributes of baobab fruit pulp
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany
Current and future pharmacological therapies for NAFLD/NASH
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues
Dental Adverse Effects of Anti-CD20 Therapies
Hepatic Encephalopathy: Pharmacological Therapies Targeting Ammonia
Review of pharmacological therapies in fibromyalgia syndrome
Review of pharmacological therapies in fibromyalgia syndrome
Drugs Targeting CD20 in Multiple Sclerosis: Pharmacology, Efficacy, Safety, and Tolerability
Nutritional and pharmacological attributes of baobab fruit pulp
Anti-CD20 therapies and pregnancy in neuroimmunologic disorders: a cohort study from Germany
Current and future pharmacological therapies for NAFLD/NASH
Current Disease-Modifying Therapies in Multiple Sclerosis
Cellular Therapies in Systemic Sclerosis: Recent Progress
A Milestone in Multiple Sclerosis Therapy: Monoclonal Antibodies Against CD20—Yet Progress Continues